Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

M. Cavo; E. Terpos; C. Nanni; P. Moreau; S. Lentzsch; S. Zweegman; J. Hillengass; M. Engelhardt; S.Z. Usmani; D.H. Vesole; J. San-Miguel; S.K. Kumar; P.G. Richardson; J.R. Mikhael; F.L. da Costa; M.-A. Dimopoulos; C. Zingaretti; N. Abildgaard; H. Goldschmidt; R.Z. Orlowski; W.J. Chng; H. Einsele; S. Lonial; B. Barlogie; K.C. Anderson; S.V. Rajkumar; B.G.M. Durie; E. Zamagni

doi:10.1016/S1470-2045(17)30189-4

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

M. Cavo, E. Terpos, C. Nanni, P. Moreau, S. Lentzsch, S. Zweegman, J. Hillengass, M. Engelhardt, S.Z. Usmani, D.H. Vesole, J. San-Miguel, S.K. Kumar, P.G. Richardson, J.R. Mikhael, F.L. da Costa, M.-A. Dimopoulos, C. Zingaretti, N. Abildgaard, H. Goldschmidt, R.Z. OrlowskiW.J. Chng, H. Einsele, S. Lonial, B. Barlogie, K.C. Anderson, S.V. Rajkumar, B.G.M. Durie, E. Zamagni

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Research output: Contribution to journal › Article

Original language	Italian
Pages (from-to)	e206-e217
Journal	The Lancet Oncology
Volume	18
Issue number	4
DOIs	https://doi.org/10.1016/S1470-2045(17)30189-4
Publication status	Published - 2017

Access to Document

10.1016/S1470-2045(17)30189-4

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016496334&doi=10.1016%2fS1470-2045%2817%2930189-4&partnerID=40&md5=76ee8da5d07e8445bbac929c44833765

Cite this

Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., San-Miguel, J., Kumar, S. K., Richardson, P. G., Mikhael, J. R., da Costa, F. L., Dimopoulos, M-A., Zingaretti, C., Abildgaard, N., Goldschmidt, H., ... Zamagni, E. (2017). Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. The Lancet Oncology, 18(4), e206-e217. https://doi.org/10.1016/S1470-2045(17)30189-4

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. / Cavo, M.; Terpos, E.; Nanni, C.; Moreau, P.; Lentzsch, S.; Zweegman, S.; Hillengass, J.; Engelhardt, M.; Usmani, S.Z.; Vesole, D.H.; San-Miguel, J.; Kumar, S.K.; Richardson, P.G.; Mikhael, J.R.; da Costa, F.L.; Dimopoulos, M.-A.; Zingaretti, C.; Abildgaard, N.; Goldschmidt, H.; Orlowski, R.Z.; Chng, W.J.; Einsele, H.; Lonial, S.; Barlogie, B.; Anderson, K.C.; Rajkumar, S.V.; Durie, B.G.M.; Zamagni, E.

In: The Lancet Oncology, Vol. 18, No. 4, 2017, p. e206-e217.

Research output: Contribution to journal › Article

Cavo, M, Terpos, E, Nanni, C, Moreau, P, Lentzsch, S, Zweegman, S, Hillengass, J, Engelhardt, M, Usmani, SZ, Vesole, DH, San-Miguel, J, Kumar, SK, Richardson, PG, Mikhael, JR, da Costa, FL, Dimopoulos, M-A, Zingaretti, C, Abildgaard, N, Goldschmidt, H, Orlowski, RZ, Chng, WJ, Einsele, H, Lonial, S, Barlogie, B, Anderson, KC, Rajkumar, SV, Durie, BGM & Zamagni, E 2017, 'Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group', The Lancet Oncology, vol. 18, no. 4, pp. e206-e217. https://doi.org/10.1016/S1470-2045(17)30189-4

Cavo, M. ; Terpos, E. ; Nanni, C. ; Moreau, P. ; Lentzsch, S. ; Zweegman, S. ; Hillengass, J. ; Engelhardt, M. ; Usmani, S.Z. ; Vesole, D.H. ; San-Miguel, J. ; Kumar, S.K. ; Richardson, P.G. ; Mikhael, J.R. ; da Costa, F.L. ; Dimopoulos, M.-A. ; Zingaretti, C. ; Abildgaard, N. ; Goldschmidt, H. ; Orlowski, R.Z. ; Chng, W.J. ; Einsele, H. ; Lonial, S. ; Barlogie, B. ; Anderson, K.C. ; Rajkumar, S.V. ; Durie, B.G.M. ; Zamagni, E. / Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. In: The Lancet Oncology. 2017 ; Vol. 18, No. 4. pp. e206-e217.

@article{74098a5276c04a4a943c891f359caa52,

title = "Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group",

author = "M. Cavo and E. Terpos and C. Nanni and P. Moreau and S. Lentzsch and S. Zweegman and J. Hillengass and M. Engelhardt and S.Z. Usmani and D.H. Vesole and J. San-Miguel and S.K. Kumar and P.G. Richardson and J.R. Mikhael and {da Costa}, F.L. and M.-A. Dimopoulos and C. Zingaretti and N. Abildgaard and H. Goldschmidt and R.Z. Orlowski and W.J. Chng and H. Einsele and S. Lonial and B. Barlogie and K.C. Anderson and S.V. Rajkumar and B.G.M. Durie and E. Zamagni",

note = "Cited By :14 Export Date: 22 February 2018",

year = "2017",

doi = "10.1016/S1470-2045(17)30189-4",

language = "Italian",

volume = "18",

pages = "e206--e217",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

AU - Cavo, M.

AU - Terpos, E.

AU - Nanni, C.

AU - Moreau, P.

AU - Lentzsch, S.

AU - Zweegman, S.

AU - Hillengass, J.

AU - Engelhardt, M.

AU - Usmani, S.Z.

AU - Vesole, D.H.

AU - San-Miguel, J.

AU - Kumar, S.K.

AU - Richardson, P.G.

AU - Mikhael, J.R.

AU - da Costa, F.L.

AU - Dimopoulos, M.-A.

AU - Zingaretti, C.

AU - Abildgaard, N.

AU - Goldschmidt, H.

AU - Orlowski, R.Z.

AU - Chng, W.J.

AU - Einsele, H.

AU - Lonial, S.

AU - Barlogie, B.

AU - Anderson, K.C.

AU - Rajkumar, S.V.

AU - Durie, B.G.M.

AU - Zamagni, E.

N1 - Cited By :14 Export Date: 22 February 2018

PY - 2017

Y1 - 2017

U2 - 10.1016/S1470-2045(17)30189-4

DO - 10.1016/S1470-2045(17)30189-4

M3 - Articolo

VL - 18

SP - e206-e217

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -